CYTK

Cytokinetics, Incorporated

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$66.73

Market Cap

$8.22B

Beta

0.51

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+376.56%

EPS Growth (YoY)-23.91%

Revenue CAGR 3Y-2.36%

P/E Ratio0.0

PEG Ratio—

FCF Yield-6.51%

Debt / Equity0.00

Interest Coverage-5.9x

No credit card required

Already have an account? Sign in to view the full analysis for CYTK.